The European Commission’s Take On Novel Genomic Techniques (NGTs) In Light Of CJEU’s Ruling In Case C-528/16
By EsqSocial Corporation 26/05/21
The decision of the Court of Justice of the European Union (CJEU) in case C-528/16 essentially banning novel genomic techniques (NGTs), in particular novel mutagenesis technologies such as CRISPR-Cas9, left the community in awe......
By: Morrison & Foerster LLP